PURR
NASDAQ · Biotechnology

Hyperliquid Strategies

Mid-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$8.91
-0.24 (-2.62%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +90.2% upside
Low Target $12.34
Average Target $16.95
High Target $26.10
Current Price $8.91
Current
$8.91
Target
$16.95
$12.34 $16.95 avg $26.10
Scenario Analysis
Bear Case
$12.34
38.5%
Low target
Base Case
$16.95
+90.2%
Avg target
Bull Case
$26.10
+192.9%
High target
Risk/Reward
5.0x
Highly favorable
Price in Context
52-Week High
$14.76
-39.6% from high
52-Week Low
$3.01
+196.0% from low
Target vs 52W High
$16.95
+14.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
 Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
 Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
 Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
 Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
 Strong Buy 31 94% $114.11 -35.3%